Vanja Zeremski
6PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 07, 2025
Efficacy and safety of first-line high-dose cytarabine in patients with primary CNS lymphoma ineligible for high-dose methotrexate: A case series.Vanja Zeremski, Tobias Ronny Haage, Dimitrios Mougiakakos
|Jan 02, 2024
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.Vanja Zeremski, Louisa Adolph, Sina Beer
|Mar 22, 2023
Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.Vanja Zeremski, Ellen D McPhail, Thomas M Habermann
|Nov 10, 2019
Is bendamustine-rituximab a reasonable treatment in selected older patients with diffuse large B cell lymphoma? Results from a multicentre, retrospective study.Vanja Zeremski, Kathleen Jentsch-Ullrich, Christoph Kahl
|Aug 09, 2019
Dose reduction and high-risk disease as risk factors for early death in primary CNS lymphoma.Vanja Zeremski, Thomas Fischer, Enrico Schalk
Pageof 1
Frequent Collaborators
2 joint publications
Dimitrios Mougiakakos
1 joint publications
Enrico Schalk
1 joint publications
Ellen D McPhail
1 joint publications
Thomas M Habermann
1 joint publications
Francesca Schieppati
1 joint publications
Niklas Gebauer
1 joint publications
Theodoros P Vassilakopoulos
1 joint publications
Louisa Adolph
1 joint publications
Sina Beer
1 joint publications
Mirjeta Berisha